NCT00085878 Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors Status COMPLETED Phase PHASE1
NCT00085813 Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00085020 GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu Status COMPLETED Phase PHASE1
NCT00082394 A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV Status COMPLETED Phase PHASE4
NCT00079911 A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons Status TERMINATED Phase PHASE4
NCT00078572 Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00075270 Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00075049 Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria Status COMPLETED Phase PHASE1/PHASE2
NCT00073008 A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00071760 Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects Status COMPLETED Phase PHASE2
NCT00069836 Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies. Status COMPLETED Phase PHASE3
NCT00067951 A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics Status COMPLETED Phase PHASE3
NCT00067561 Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy Status COMPLETED Phase PHASE3
NCT00067457 Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy Status COMPLETED Phase PHASE3
NCT00065182 Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2